EXPLORNA

Welcome to the Brand page for “EXPLORNA”, which is offered here for Human vaccine preparations; vaccine adjuvants; medicinal preparations for the treatment of cancer, infectious diseases, metabolic diseases, allergic diseases, autoimmune diseases, cardiovascular diseases, diseases of the nervous system, diseases of gastrointestinal system, diseases of respiratory system, diseases of skin, diseases of secretory systems, diseases of bones and joints, diseases of hematopoietic system and animal diseases; nucleic acid sequences and chemical reagents for medical and veterinary purposes;explore rna;medical analysis for the diagnosis and treatment of persons; medical analysis services in the nature of rna or dna analysis for the diagnosis and prognosis of cancer; consultancy services relating to health care; medical services in the fields of oncology, dentistry, ophthalmology, transplant medicine, infectious diseases, metabolic diseases, allergic diseases, autoimmune diseases, cardiovascular diseases, diseases of the nervous system, diseases of gastrointestinal system, diseases of respiratory system, diseases of skin, diseases of secretory systems, diseases of bones and joints, and diseases of hematopoietic system;research and development of mrna therapeutics; biochemical research and development; research and development of vaccines and medicines; pharmaceutical products development; testing, inspection, research, or development of pharmaceutical preparations for gene therapy; working on and evaluation of chemical syntheses;.

Its status is currently believed to be active. Its class is unavailable. “EXPLORNA” is believed to be currently owned by “EXPLORNA THERAPEUTICS SPÓLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA”.